Tag: ALNY

Analysts Viewpoint

Alnylam Pharmaceuticals Inc [ALNY] Records 200-Day SMA of $233.85

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Alnylam Pharmaceuticals

Insiders Updates

An Analysis of Alnylam Pharmaceuticals Inc (ALNY)’s Potential Price Growth

Alnylam Pharmaceuticals Inc’s recent filing unveils that its Director SHARP PHILLIP A unloaded Company’s shares for reported $3.09 million on

Insiders Updates

ALNY’s latest rating updates from top analysts.

Alnylam Pharmaceuticals Inc’s recent filing unveils that its CMO & EVP Dev & Med Affairs Garg Pushkal unloaded Company’s shares

ZOM Stock

Analysts Viewpoint

Selling Buzz: Alnylam Pharmaceuticals Inc [ALNY] CMO & EVP Dev & Med Affairs Garg Pushkal sells 1,752 shares of the company

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Analyzing Alnylam Pharmaceuticals Inc (ALNY) After Recent Trading Activity

In a filing, Alnylam Pharmaceuticals Inc revealed its CMO & EVP Dev & Med Affairs Garg Pushkal unloaded Company’s shares

Analysts Viewpoint

ALNY Shares Experience Surge in Value

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Alnylam Pharmaceuticals

CHWY Stock

Stock Earnings

An Analysis of Alnylam Pharmaceuticals Inc (ALNY)’s Potential Price Growth

Alnylam Pharmaceuticals Inc’s filing revealed that its CMO & EVP Dev & Med Affairs Garg Pushkal unloaded Company’s shares for